Regenerative Biology for Longevity and Healthier Lives

Advancing stem cell science to address unmet needs in chronic pain and metabolic disorders

Current Trials

BRTX-100: Phase 2 Clinical Trial

A Single Dose of BRTX-100 for Patients With Chronic Lumbar Disc Disease (cLDD)

Recruiting

Learn more about BioRestorative’s current ongoing Phase 2 clinical trial.
Search for study ID number: NCT04042844 at clinicaltrials.gov.

clinicaltrials.gov

ABOUT US

BioRestorative Therapies

Developing therapeutic products using advanced cell and tissue protocols, primarily involving adult stem cells. Our clinical programs address critical healthcare needs, including degenerative disc disease and metabolic disorders, while our BioCosmeceutical platform explores innovative applications in aesthetic medicine.

NASDAQ:BRTX

Learn More

Our Products

DEVELOPMENT

Bone marrow derived mesenchymal stem cells

Brown adipose derived stem cells

COMMERCIAL

Secretome (novel exosome, growth factor/cytokine) biologics based technology for cosmetic applications

Latest News

Press Releases

Explore BioRestorative’s latest press releases
View Press Releases

Latest Presentation

View our most recent company overview and investment highlights
Learn More

Email Alerts

Sign up today and receive company updates straight to your inbox
Sign Up